BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18710978)

  • 1. Breast tumor xenografts: diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody.
    Kim H; Morgan DE; Zeng H; Grizzle WE; Warram JM; Stockard CR; Wang D; Zinn KR
    Radiology; 2008 Sep; 248(3):844-51. PubMed ID: 18710978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early therapy assessment of combined anti-DR5 antibody and carboplatin in triple-negative breast cancer xenografts in mice using diffusion-weighted imaging and (1)H MR spectroscopy.
    Zhai G; Kim H; Sarver D; Samuel S; Whitworth L; Umphrey H; Oelschlager DK; Beasley TM; Zinn KR
    J Magn Reson Imaging; 2014 Jun; 39(6):1588-94. PubMed ID: 24151215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging.
    Kim H; Morgan DE; Buchsbaum DJ; Zeng H; Grizzle WE; Warram JM; Stockard CR; McNally LR; Long JW; Sellers JC; Forero A; Zinn KR
    Cancer Res; 2008 Oct; 68(20):8369-76. PubMed ID: 18922909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravoxel incoherent motion diffusion-weighted imaging for monitoring chemotherapeutic efficacy in gastric cancer.
    Song XL; Kang HK; Jeong GW; Ahn KY; Jeong YY; Kang YJ; Cho HJ; Moon CM
    World J Gastroenterol; 2016 Jun; 22(24):5520-31. PubMed ID: 27350730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volumetric contrast-enhanced ultrasound imaging to assess early response to apoptosis-inducing anti-death receptor 5 antibody therapy in a breast cancer animal model.
    Hoyt K; Sorace A; Saini R
    J Ultrasound Med; 2012 Nov; 31(11):1759-66. PubMed ID: 23091246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DCE-MRI detects early vascular response in breast tumor xenografts following anti-DR5 therapy.
    Kim H; Folks KD; Guo L; Stockard CR; Fineberg NS; Grizzle WE; George JF; Buchsbaum DJ; Morgan DE; Zinn KR
    Mol Imaging Biol; 2011 Feb; 13(1):94-103. PubMed ID: 20383593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11.
    Oliver PG; LoBuglio AF; Zinn KR; Kim H; Nan L; Zhou T; Wang W; Buchsbaum DJ
    Clin Cancer Res; 2008 Apr; 14(7):2180-9. PubMed ID: 18381960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model.
    Buchsbaum DJ; Zhou T; Grizzle WE; Oliver PG; Hammond CJ; Zhang S; Carpenter M; LoBuglio AF
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3731-41. PubMed ID: 14506165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of anti-DR5 and chemotherapy on basal-like breast cancer.
    Oliver PG; LoBuglio AF; Zhou T; Forero A; Kim H; Zinn KR; Zhai G; Li Y; Lee CH; Buchsbaum DJ
    Breast Cancer Res Treat; 2012 Jun; 133(2):417-26. PubMed ID: 21901385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor activity of an anti-DR5 monoclonal antibody, TRA-8, in combination with taxane/platinum-based chemotherapy in an ovarian cancer model.
    Bevis KS; McNally LR; Sellers JC; Della Manna D; Londoño Joshi A; Amm H; Straughn JM; Buchsbaum DJ
    Gynecol Oncol; 2011 Apr; 121(1):193-9. PubMed ID: 21211830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma.
    Kim H; Zhai G; Samuel SL; Rigell CJ; Umphrey HR; Rana S; Stockard CR; Fineberg NS; Zinn KR
    Mol Cancer Ther; 2012 Feb; 11(2):405-15. PubMed ID: 22203731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of TRA-8 anti-death receptor 5 antibody in combination with chemotherapy in an ex vivo human ovarian cancer model.
    Frederick PJ; Kendrick JE; Straughn JM; Della Manna DL; Oliver PG; Lin HY; Grizzle WE; Stockard CR; Alvarez RD; Zhou T; LoBuglio AF; Buchsbaum DJ
    Int J Gynecol Cancer; 2009 Jul; 19(5):814-9. PubMed ID: 19574765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion weighted imaging evaluated the early therapy effect of tamoxifen in an MNU-induced mammary cancer rat model.
    Zhai G; Grubbs CJ; Stockard CR; Umphrey HR; Beasley TM; Kim H
    PLoS One; 2013; 8(5):e64445. PubMed ID: 23700476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of small cell lung cancer with TRA-8 in combination with cisplatin and radiation.
    Bonner JA; Willey CD; Yang ES; Dobelbower MC; Sanford LL; Bright SJ; Buchsbaum DJ; Raisch KP
    Radiother Oncol; 2011 Oct; 101(1):183-9. PubMed ID: 21722984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model.
    Straughn JM; Oliver PG; Zhou T; Wang W; Alvarez RD; Grizzle WE; Buchsbaum DJ
    Gynecol Oncol; 2006 Apr; 101(1):46-54. PubMed ID: 16271751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial diffusion MRI to monitor and model treatment response of the targeted nanotherapy CRLX101.
    Ng TS; Wert D; Sohi H; Procissi D; Colcher D; Raubitschek AA; Jacobs RE
    Clin Cancer Res; 2013 May; 19(9):2518-27. PubMed ID: 23532891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumoricidal activity of combining the agonistic DR5 antibody D-6 with cisplatin in C30 cisplatin-resistant ovarian cancer in vitro and in vivo.
    Huang Y; Liang B; Jiang Q; Chen C; Yang K; Li C; Zheng A
    Mol Med Rep; 2014 Jul; 10(1):183-90. PubMed ID: 24789319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy response evaluation in a mouse model of gastric cancer using intravoxel incoherent motion diffusion-weighted MRI and histopathology.
    Cheng J; Wang Y; Zhang CF; Wang H; Wu WZ; Pan F; Hong N; Deng J
    World J Gastroenterol; 2017 Mar; 23(11):1990-2001. PubMed ID: 28373765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of weimaining on apoptosis and Caspase-3 expression in a breast cancer mouse model.
    Ke H; Wang X; Zhou Z; Ai W; Wu Z; Zhang Y
    J Ethnopharmacol; 2021 Jan; 264():113363. PubMed ID: 32916234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of proapoptotic anticancer therapeutic response in vivo based on cell death visualization and TRAIL death ligand-receptor interaction.
    Zhou L; Wang W; Dicker DT; Humphreys RC; El-Deiry WS
    Cancer Biol Ther; 2011 Aug; 12(4):335-48. PubMed ID: 21785270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.